QURE uniQure N.V. - Ordinary Shares
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Lug 29, 2026
$23,46
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$8,73minimo 52 sett.
$71,50massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$1.63B
P/E (TTM)
-5.8
EPS (TTM)
$-4.02
Ricavi (TTM)
$19M
i tuoi badge
Intervallo 52 sett.
$9–$72
Rating Analisti
BUY
Prezzo Obiettivo
$65
P/E
-5.8
ROE
-157.6%
Margine di Profitto Netto
-1350.7%
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
QURE Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$23.46
Capitalizzazione di Mercato (MRQ)
$1.63B
P/E (TTM)
-5.8
EPS (TTM)
$-4.02
Ricavi (TTM)
$19M
ROE (TTM)
-157.6%
D/E Debito/Patrimonio (MRQ)
0.2
Intervallo 52 sett.
$9–$72
QURE Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$16M2016-12-31 → 2025-12-31
EPS$-3.462019-12-31 → 2025-12-31
Flusso di cassa libero$-178M2016-12-31 → 2025-12-31
Margine netto-1350.7%2017-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | QURE | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E (TTM) | -5.8media 5 anni ≈-3.4 | ≈-3.4 | · | · | |
| P/S (TTM) | 87.1media 5 anni ≈31.4 | ≈31.4 | · | · | |
| P/B (MRQ) | 5.0media 5 anni ≈-23.0 | ≈-23.0 | · | · | |
| EV / EBITDA | -7.8media 5 anni ≈-3.5 | ≈-3.5 | · | · | |
| Prezzo / FCF (TTM) | -10.1media 5 anni ≈-3.6 | ≈-3.6 | · | · | |
| Prezzo / Flusso di cassa (TTM) | -10.1media 5 anni ≈-3.9 | ≈-3.9 | · | · | |
| EV / Revenue (EV / Ricavi) | 90.0media 5 anni ≈28.0 | ≈28.0 | · | · | |
| EV / FCF | -8.1media 5 anni ≈-3.5 | ≈-3.5 | · | · | |
| Prezzo / Valore contabile tangibile (MRQ) | 6.2media 5 anni ≈5.5 | ≈5.5 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | QURE | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Margine Operativo (TTM) | -1071.5%media 5 anni ≈-738.3% | ≈-738.3% | · | · | |
| EBITDA Margin (Margine EBITDA) | -1151.4%media 5 anni ≈-738.3% | ≈-738.3% | · | · | |
| Margine ante imposte (TTM) | -1313.0%media 5 anni ≈-813.5% | ≈-813.5% | · | · | |
| Margine di Profitto Netto (TTM) | -1350.7%media 5 anni ≈-824.5% | ≈-824.5% | · | · | |
| ROA (TTM) | -32.1%media 5 anni ≈-12.6% | ≈-12.6% | · | · | |
| ROE (TTM) | -157.6%media 5 anni ≈-256.6% | ≈-256.6% | · | · | |
| ROIC | -76.7%media 5 anni ≈-113.3% | ≈-113.3% | · | · |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | QURE | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto (MRQ) | 0.2media 5 anni ≈-1.3 | ≈-1.3 | · | · | |
| Rapporto corrente (MRQ) | 10.0media 5 anni ≈10.5 | ≈10.5 | · | · | |
| Quick Ratio | 1.3media 5 anni ≈5.3 | ≈5.3 | · | · | |
| Debito a lungo termine / Patrimonio netto (MRQ) | 0.2media 5 anni ≈-1.3 | ≈-1.3 | · | · |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | QURE | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | -40.6%media 5 anni ≈232.5% | ≈232.5% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | -46.7%media 5 anni ≈-44.8% | ≈-44.8% | · | · | |
| Revenue CAGR 5Y (CAGR Ricavi 5Y) | -15.6% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | QURE | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 0.0media 5 anni ≈0.2 | ≈0.2 | · | · | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$72.8K | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-2.1%
Prossimo report
Nov 09, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | $-1.22 | $-0.84 | -45.1% | |
| 31 Marzo 2026 | Mag 12, 2026 | $-0.85 | $-0.89 | 4.9% |
| 31 Dicembre 2025 | $-0.64 | $-0.97 | 33.7% | |
| 30 Settembre 2025 | $-1.38 | $-0.92 | -50.4% | |
| 30 Giugno 2025 | $-0.69 | $-0.91 | 24.4% | |
| 31 Marzo 2025 | $-0.82 | $-1.03 | 20.0% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16M | $27M | $16M | $106M | $524M | $38M | $7M | $11M | $13M | $25M | $11M | |
| Cost of Revenue | $2M | $1M | $65.0K | $1M | $25M | $3M | $2M | $1M | $817.0K | $1M | · | |
| R&D Expense | $141M | $144M | $215M | $198M | $144M | $122M | $95M | $75M | $72M | $73M | $59M | |
| SG&A Expense | $65M | $53M | $75M | $55M | $56M | $43M | $34M | $25M | $25M | $26M | $23M | |
| Operating Expenses | $208M | $215M | $303M | $256M | $225M | $165M | $128M | $100M | $97M | $99M | $83M | |
| Operating Income | $-185M | $-184M | $-283M | $-143M | $311M | $-125M | $-121M | $-88M | $-71M | $-72M | $-71M | |
| Interest Expense | · | · | $42M | $12M | $7M | $4M | $4M | $2M | $2M | $2M | $3M | |
| Interest Income | $17M | $21M | $20M | $609.0K | $162.0K | $938.0K | $4M | $3M | $117.0K | $70.0K | $121.0K | |
| Other Non-op | $11M | · | · | $3M | $-160.0K | $483.0K | $-3M | $208.0K | $-2M | $785.0K | $-7M | |
| Pretax Income | $-193M | $-237M | $-307M | $-128M | $333M | $-141M | $-124M | $-83M | $-79M | $-72M | $-83M | |
| Income Tax | $6M | $2M | $2M | $-1M | $3M | $-16M | · | $231.0K | $-199.0K | $1M | $-1M | |
| Net Income | $-199M | $-240M | $-308M | $-127M | $330M | $-125M | $-124M | $-83M | $-79M | $-73M | $-82M | |
| EPS (Basic) | $-3.46 | $-4.92 | $-6.47 | $-2.71 | $7.17 | $-2.81 | $-3.11 | · | · | · | · | |
| EPS (Diluted) | $-3.46 | $-4.92 | $-6.47 | $-2.71 | $7.04 | $-2.81 | $-3.11 | · | · | · | · | |
| Shares (Basic) | 57,502,068 | 48,649,129 | 47,670,986 | 46,735,045 | 45,986,467 | 44,466,365 | 39,999,450 | · | · | · | · | |
| Shares (Diluted) | 57,502,068 | 48,649,129 | 47,670,986 | 46,735,045 | 46,840,972 | 44,466,365 | 39,999,450 | · | · | · | · | |
| EBITDA | $-185M | $-184M | $-283M | $-143M | $311M | $-125M | $-121M | · | $-71M | $-72M | · |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $80M | $159M | $241M | $228M | $556M | $245M | $378M | $235M | $159M | $132M | $222M | |
| Receivables | $6M | · | · | · | · | $7M | · | · | · | $4M | · | |
| Inventory | · | · | $12M | $7M | · | · | · | · | · | · | $474.0K | |
| Prepaid Expense | $21M | $9M | $15M | $12M | $11M | $4M | $5M | $1M | $1M | $996.0K | $690.0K | |
| Other Current Assets | · | · | · | · | · | $3M | $748.0K | $329.0K | $687.0K | $1M | $1M | |
| Current Assets | $656M | $390M | $652M | $477M | $628M | $259M | $384M | $237M | $163M | $144M | $228M | |
| PP&E (Net) | $14M | $20M | $47M | $51M | $44M | $32M | $29M | $29M | $34M | $36M | $26M | |
| PP&E (Gross) | $58M | $52M | $102M | $95M | $80M | $68M | $57M | $52M | $51M | $48M | $37M | |
| Accum. Depreciation | $44M | $32M | $56M | $44M | $37M | $35M | $29M | $23M | $17M | $12M | $11M | |
| Goodwill | $25M | $22M | $26M | $26M | $28M | $542.0K | $496.0K | $506.0K | $530.0K | $465.0K | $481.0K | |
| Intangibles | $73M | $71M | $60M | $59M | $63M | $3M | $5M | $5M | $10M | $8M | $7M | |
| Other Non-current Assets | $6M | $1M | $3M | $6M | $6M | $3M | · | · | $2M | $2M | $1M | |
| Total Assets | $825M | $557M | $832M | $705M | $809M | $340M | $449M | $274M | $210M | $190M | $263M | |
| Accounts Payable | $5M | $7M | $7M | $11M | $3M | $4M | $6M | $4M | $3M | $6M | $4M | |
| Accrued Liabilities | $41M | $29M | $31M | $31M | $28M | $18M | $12M | $8M | · | · | · | |
| Current Liabilities | $63M | $40M | $74M | $76M | $37M | $27M | $32M | $20M | $19M | $23M | $27M | |
| Capital Leases | $10M | $11M | $28M | $32M | $29M | $30M | $31M | · | · | · | · | |
| Deferred Tax | $8M | $7M | $8M | $8M | $13M | · | · | · | · | · | · | |
| Other Non-current Liabilities | $4M | $8M | $4M | $935.0K | $4M | $3M | $534.0K | $435.0K | $614.0K | $51.0K | $578.0K | |
| Total Liabilities | $626M | $563M | $624M | $229M | $213M | $96M | $126M | $94M | $120M | $127M | $135M | |
| Long-term Debt | $72M | $66M | $148M | $144M | $136M | $42M | $47M | $48M | $24M | $20M | $20M | |
| Total Debt | $50M | $51M | $102M | $103M | $101M | $36M | $36M | · | $21M | $20M | · | |
| Common Stock | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | |
| Paid-in Capital | $1.58B | $1.17B | $1.15B | $1.11B | $1.08B | $1.02B | $987M | $720M | $567M | $465M | $456M | |
| Retained Earnings | $-1.33B | $-1.13B | $-890M | $-582M | $-455M | $-785M | $-660M | $-536M | $-475M | $-396M | $-323M | |
| AOCI | $-58M | $-53M | $-54M | $-58M | $-29M | $-10M | $-7M | $-7M | $-4M | $-7M | $-7M | |
| Stockholders' Equity | $199M | $-7M | $208M | $476M | $596M | $244M | $323M | $180M | $89M | $64M | $128M | |
| Liabilities + Equity | $825M | $557M | $832M | $705M | $809M | $340M | $449M | $274M | $210M | $190M | $263M | |
| Shares Outstanding | 62,336,717 | 48,988,087 | 47,833,830 | 46,968,032 | 46,298,635 | 44,777,799 | 43,711,954 | 37,351,653 | 31,339,040 | 25,257,420 | 24,327,944 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $15M | $13M | $12M | $9M | $7M | $11M | $7M | $12M | $8M | · | · | |
| Stock-based Comp | $18M | $22M | $35M | $34M | $26M | $22M | $18M | $11M | $10M | $6M | $12M | |
| Deferred Tax | $2M | $2M | $2M | $-1M | $3M | $-16M | · | $209.0K | $-209.0K | $1M | $-1M | |
| Restructuring | · | · | $3M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-178M | $-183M | $-146M | $-145M | $288M | $-135M | $-99M | $-76M | $-64M | $-72M | $7M | |
| CapEx | $439.0K | $3M | $7M | $18M | $17M | $7M | $6M | $2M | $4M | $15M | $8M | |
| Investing Cash Flow | $-322M | $163M | $-206M | $-183M | $-67M | $-9M | $-7M | $-4M | $-6M | $-17M | $-8M | |
| Debt Issued | · | · | · | · | $64M | · | · | $15M | · | · | · | |
| Net Debt Issued | · | $-53M | · | · | $64M | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | $31M | $7M | $6M | $5M | $4M | $3M | $3M | |
| Net Stock Activity | · | · | · | · | $3M | $7M | $6M | · | $4M | $3M | · | |
| Financing Cash Flow | $415M | $-59M | $363M | $1M | $95M | $7M | $249M | $158M | $90M | $2M | $161M | |
| Net Change in Cash | $-79M | $-84M | $13M | $-328M | $312M | $-133M | $143M | $75M | $28M | $-89M | $157M | |
| Taxes Paid | $8M | $21.0K | $12.0K | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-178M | $-186M | $-153M | $-163M | $271M | $-142M | $-104M | · | $-69M | $-87M | · | |
| Levered FCF | · | · | $-195M | $-174M | $263M | $-145M | · | · | $-71M | $-90M | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1151.4% | -679.6% | -1785.5% | -134.4% | 59.3% | -334.3% | -1663.8% | · | -544.3% | -286.7% | · | |
| Net Margin | -1236.0% | -883.4% | -1947.1% | -119.1% | 62.9% | -333.3% | -1705.8% | · | -604.7% | · | · | |
| Pretax Margin | -1201.0% | -874.4% | -1935.0% | -120.4% | 63.5% | -377.0% | -1705.8% | · | -606.2% | -287.8% | · | |
| EBITDA Margin | -1151.4% | -679.6% | -1785.5% | -134.4% | 59.3% | -334.3% | -1663.8% | · | -544.3% | -286.7% | · | |
| ROA | -28.8% | -34.5% | -40.2% | -16.8% | 57.3% | -31.7% | -34.4% | · | -39.6% | · | · | |
| ROE | -204.2% | -976.4% | -129.5% | -28.3% | 55.6% | -53.0% | -36.9% | · | -103.6% | · | · | |
| ROIC | -76.7% | -417.7% | -92.0% | -24.4% | 44.1% | -39.7% | · | · | -64.6% | -87.2% | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.4 | 9.7 | 8.8 | 6.3 | 17.1 | 9.5 | 12.1 | · | 8.5 | 6.3 | · | |
| Quick Ratio | 1.3 | 4.0 | 3.3 | 3.0 | 15.1 | 9.2 | 11.9 | · | 8.3 | 6.0 | · | |
| Debt / Equity | 0.2 | -7.6 | 0.5 | 0.2 | 0.2 | 0.1 | 0.1 | · | 0.2 | 0.3 | · | |
| LT Debt / Equity | 0.2 | -7.6 | 0.5 | 0.2 | 0.2 | 0.1 | 0.1 | · | 0.2 | 0.3 | · | |
| Interest Coverage | · | · | -6.8 | -12.2 | 41.6 | -32.8 | -31.8 | · | -32.0 | -33.1 | · |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.1 | 0.9 | 0.1 | 0.0 | · | 0.1 | 0.1 | · | |
| Inventory Turnover | · | · | 0.0 | 0.3 | · | · | · | · | · | · | · | |
| Receivables Turnover | · | · | · | · | · | 7.3 | · | · | · | 13.6 | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.19 | $-0.14 | $4.34 | $10.13 | $12.87 | $5.45 | $7.39 | · | $2.85 | $2.52 | · | |
| Revenue / Share | $0.28 | $0.56 | $0.33 | $2.28 | $11.19 | · | · | · | · | · | · | |
| Cash Flow / Share | $-3.09 | $-3.76 | $-3.06 | $-3.10 | $6.15 | · | · | · | · | · | · | |
| Cash / Share | $1.29 | $3.24 | $5.05 | $4.85 | $12.01 | $5.47 | $8.64 | · | $5.09 | $5.25 | · | |
| EPS (TTM) | $-3.46 | $-4.92 | $-6.47 | $-2.71 | $7.04 | $-2.81 | $-3.11 | · | · | · | · |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -40.6% | 71.2% | -85.1% | -79.7% | 1296.8% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -46.7% | -62.7% | -25.0% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -15.6% | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $16M | $27M | $16M | $106M | $524M | $38M | $7M | $11M | $13M | $25M | · | |
| Net Income TTM | $-199M | $-240M | $-308M | $-127M | $330M | $-125M | $-124M | $-83M | $-79M | $-73M | · | |
| Market Cap | $1.49B | $865M | $324M | $1.06B | $960M | $1.62B | $3.13B | · | $614M | $141M | · | |
| Enterprise Value | $1.46B | $758M | $184M | $940M | $505M | $1.41B | $2.79B | · | $475M | $29M | · | |
| P/E | -6.9 | -3.6 | -1.0 | -8.4 | 2.9 | -12.9 | -23.0 | · | · | · | · | |
| P/S | 92.7 | 31.9 | 20.4 | 10.0 | 1.8 | 43.1 | 430.2 | · | 46.8 | 5.6 | · | |
| P/B | 7.5 | -128.1 | 1.6 | 2.2 | 1.6 | 6.6 | 9.7 | · | 6.9 | 2.2 | · | |
| P / Tangible Book | 14.8 | · | 2.7 | 2.7 | 1.9 | 6.7 | · | · | · | · | · | |
| P / Cash Flow | -8.4 | -4.7 | -2.2 | -7.3 | 3.3 | -12.0 | -31.7 | · | -9.6 | -2.0 | · | |
| P / FCF | -8.4 | -4.6 | -2.1 | -6.5 | 3.5 | -11.4 | -30.0 | · | -8.9 | -1.6 | · | |
| EV / EBITDA | -7.9 | -4.1 | -0.7 | -6.6 | 1.6 | -11.2 | -23.0 | · | -6.7 | -0.4 | · | |
| EV / FCF | -8.2 | -4.1 | -1.2 | -5.8 | 1.9 | -9.9 | -26.7 | · | -6.9 | -0.3 | · | |
| EV / Revenue | 90.8 | 27.9 | 11.6 | 8.8 | 1.0 | 37.5 | 383.3 | · | 36.3 | 1.2 | · | |
| Earnings Yield | -14.5% | -27.9% | -95.6% | -11.9% | 33.9% | -7.8% | -4.3% | · | · | · | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6M | $4M | $6M | $4M | $5M | $2M | $5M | $2M | $11M | $8M | $7M | $1M | $2M | $5M | $103M | $1M | |
| Cost of Revenue | $350.0K | $219.0K | $435.0K | $398.0K | $656.0K | $197.0K | $619.0K | $264.0K | $234.0K | $150.0K | · | · | · | · | · | · | |
| R&D Expense | $34M | $29M | $35M | $34M | $35M | $36M | $39M | $31M | $34M | $41M | $43M | $65M | $46M | $61M | $58M | $48M | |
| SG&A Expense | $17M | $20M | $22M | $19M | $14M | $11M | $11M | $12M | $16M | $14M | $17M | $18M | $21M | $18M | $18M | $13M | |
| Operating Expenses | $52M | $49M | $57M | $54M | $50M | $47M | $51M | $43M | $57M | $64M | $69M | $84M | $69M | $81M | $78M | $62M | |
| Operating Income | $-52M | $-46M | $-51M | $-51M | $-44M | $-39M | $-46M | $-40M | $-44M | $-54M | $-62M | $-82M | $-65M | $-74M | $26M | $-60M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $16M | · | $15M | $7M | $4M | · | $3M | |
| Interest Income | $5M | $5M | $6M | $4M | $4M | $4M | $4M | $5M | $6M | $7M | $7M | $7M | $3M | $2M | $493.0K | $39.0K | |
| Other Non-op | $-16M | $4M | $18M | $-7M | · | · | · | · | · | · | · | · | · | · | $2M | $0 | |
| Pretax Income | $-79M | $-53M | $-41M | $-72M | $-37M | $-43M | $-72M | $-44M | $-55M | $-65M | $-70M | $-90M | $-68M | $-78M | $7M | $-48M | |
| Income Tax | $2M | $488.0K | $-4M | $9M | $425.0K | $496.0K | $856.0K | $-31.0K | $948.0K | $656.0K | $3M | $-69.0K | $163.0K | $-1M | $-207.0K | $-329.0K | |
| Net Income | $-81M | $-54M | $-37M | $-81M | $-38M | $-44M | $-73M | $-44M | $-56M | $-66M | $-73M | $-90M | $-68M | $-77M | $7M | $-48M | |
| EPS (Basic) | $-1.22 | $-0.85 | $-0.57 | $-1.38 | $-0.69 | $-0.82 | $-1.49 | $-0.91 | $-1.16 | $-1.36 | $-1.52 | $-1.88 | $-1.44 | $-1.63 | $0.15 | $-1.02 | |
| EPS (Diluted) | $-1.22 | $-0.85 | $-0.57 | $-1.38 | $-0.69 | $-0.82 | $-1.49 | $-0.91 | $-1.16 | $-1.36 | $-1.52 | $-1.88 | $-1.44 | $-1.63 | $0.15 | $-1.02 | |
| Shares (Basic) | 66,243,879 | 62,742,847 | · | 58,516,415 | 54,807,967 | 53,110,580 | · | 48,718,533 | 48,622,440 | 48,384,510 | · | 47,770,101 | 47,649,520 | 47,436,335 | · | 46,772,430 | |
| Shares (Diluted) | 66,243,879 | 62,742,847 | · | 58,516,415 | 54,807,967 | 53,110,580 | · | 48,718,533 | 48,622,440 | 48,384,510 | · | 47,770,101 | 47,649,520 | 47,436,335 | · | 46,772,430 | |
| EBITDA | $-52M | $-46M | · | $-51M | $-44M | $-39M | · | $-40M | $-44M | $-54M | · | $-82M | $-65M | $-74M | · | $-60M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $413M | $140M | $80M | $597M | $254M | $217M | $159M | $252M | $288M | $243M | $241M | $229M | $514M | $154M | $228M | $440M | |
| Receivables | $6M | $4M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Inventory | · | · | · | · | · | · | · | · | · | $8M | · | $16M | $10M | $7M | · | $4M | |
| Prepaid Expense | $10M | $17M | $21M | $10M | $19M | $13M | $9M | $19M | $18M | $19M | · | $15M | $12M | $13M | · | $14M | |
| Current Assets | $834M | $616M | $656M | $716M | $409M | $435M | $390M | $464M | $592M | $596M | · | $694M | $757M | $443M | · | $465M | |
| PP&E (Net) | $11M | $12M | $14M | $15M | $17M | $18M | $20M | $26M | $26M | $45M | · | $46M | $49M | $50M | · | $48M | |
| PP&E (Gross) | · | · | $58M | · | · | · | $52M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $44M | $44M | $41M | $36M | $32M | $31M | $28M | $58M | · | $52M | $49M | $47M | · | $40M | |
| Goodwill | $25M | $25M | $25M | $25M | $25M | $23M | $22M | $24M | $23M | $26M | · | $25M | $26M | $26M | · | $23M | |
| Intangibles | $62M | $70M | $73M | $74M | $76M | $72M | $71M | $77M | $59M | $59M | · | $58M | $60M | $60M | · | $54M | |
| Other Non-current Assets | $5M | $6M | $6M | $5M | $5M | $5M | $1M | $1M | $5M | $5M | · | $6M | $6M | $6M | · | $6M | |
| Total Assets | $985M | $779M | $825M | $888M | $585M | $605M | $557M | $646M | $731M | $770M | · | $872M | $943M | $631M | · | $638M | |
| Accounts Payable | $5M | $4M | $5M | $6M | $6M | $5M | $7M | $5M | $4M | $5M | · | $6M | $9M | $9M | · | $8M | |
| Accrued Liabilities | $51M | $43M | $41M | $52M | $31M | $27M | $29M | $32M | $26M | $23M | · | $28M | $24M | $23M | · | $26M | |
| Current Liabilities | $83M | $59M | $63M | $101M | $41M | $36M | $40M | $71M | $80M | $63M | · | $69M | $68M | $66M | · | $64M | |
| Capital Leases | $10M | $10M | $10M | $10M | $11M | $11M | $11M | $12M | $12M | $27M | · | $29M | $30M | $31M | · | $30M | |
| Deferred Tax | $8M | $8M | $8M | $8M | $8M | $7M | $7M | $8M | $7M | $7M | · | $5M | $7M | $7M | · | $9M | |
| Other Non-current Liabilities | $3M | $3M | $4M | $6M | $6M | $6M | $8M | $9M | $3M | $3M | · | $1M | $960.0K | $958.0K | · | $3M | |
| Total Liabilities | $661M | $629M | $626M | $660M | $589M | $572M | $563M | $590M | $634M | $623M | · | $603M | $589M | $218M | · | $217M | |
| Long-term Debt | · | · | $72M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $50M | $50M | · | $52M | $52M | $52M | · | $51M | $103M | $102M | · | $101M | $101M | $103M | · | $102M | |
| Common Stock | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Paid-in Capital | $1.84B | $1.59B | $1.58B | $1.58B | $1.26B | $1.26B | $1.17B | $1.17B | $1.16B | $1.16B | · | $1.14B | $1.13B | $1.12B | · | $1.10B | |
| Retained Earnings | $-1.46B | $-1.38B | $-1.33B | $-1.29B | $-1.21B | $-1.17B | $-1.13B | $-1.06B | $-1.01B | $-956M | · | $-817M | $-728M | $-659M | · | $-589M | |
| AOCI | $-58M | $-60M | $-58M | $-59M | $-59M | $-54M | $-53M | $-57M | $-56M | $-56M | · | $-59M | $-52M | $-52M | $-58M | $-93M | |
| Stockholders' Equity | $324M | $149M | $199M | $229M | $-4M | $34M | $-7M | $56M | $97M | $147M | $208M | $269M | $353M | $413M | $476M | $421M | |
| Liabilities + Equity | $985M | $779M | $825M | $888M | $585M | $605M | $557M | $646M | $731M | $770M | · | $872M | $943M | $631M | · | $638M | |
| Shares Outstanding | 69,334,839 | 63,033,249 | 62,336,717 | 62,165,900 | 54,865,673 | 54,698,479 | 48,988,087 | 48,738,874 | 48,694,569 | 48,492,357 | 47,833,830 | 47,810,291 | 47,702,331 | 47,546,673 | 46,968,032 | 46,815,109 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $5M | $3M | $3M | $4M | $4M | $5M | $4M | $3M | $3M | $3M | $4M | $3M | $3M | $3M | · | $2M | |
| Stock-based Comp | $5M | $5M | $5M | $4M | $5M | $4M | $5M | $3M | $7M | $7M | $7M | $11M | $9M | $8M | $12M | $8M | |
| Deferred Tax | $2M | $500.0K | $-391.0K | $1M | $400.0K | $500.0K | $871.0K | $-120.0K | · | · | $3M | $-69.0K | $163.0K | $-1M | $-231.0K | $-329.0K | |
| Operating Cash Flow | $-29M | $-38M | $-78M | $-16M | $-40M | $-44M | $-53M | $-37M | $-33M | $-61M | $-50M | $39M | $-57M | $-78M | $-55M | $-49M | |
| CapEx | $472.0K | $140.0K | $119.0K | $-66.0K | $260.0K | $126.0K | $40.0K | $380.0K | $604.0K | $2M | $2M | $2M | $1M | $2M | $5M | $4M | |
| Investing Cash Flow | $53M | $99M | $-441M | $27M | $73M | $20M | $-27M | $48M | $78M | $64M | $60M | $-314M | $46M | $3M | $-168M | $-5M | |
| Financing Cash Flow | $249M | $550.0K | $2M | $332M | $44.0K | $81M | $-7M | $-53M | · | · | $46.0K | $-8M | $370M | $131.0K | $601.0K | $301.0K | |
| Net Change in Cash | $273M | $60M | $-517M | $343M | $37M | $58M | $-93M | $-38M | $45M | $2M | $12M | $-284M | $360M | $-74M | $-212M | $-60M | |
| Free Cash Flow | · | $-38M | · | · | · | $-44M | · | · | · | $-63M | · | · | · | $-81M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-79M | · | · | · | $-84M | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -893.7% | -1283.5% | · | -1379.0% | -833.6% | -2510.0% | · | -1759.0% | -395.6% | -639.1% | · | -5819.3% | -2686.8% | -1392.9% | · | -4107.5% | |
| Net Margin | -1387.8% | -1503.0% | · | -2175.9% | -716.8% | -2784.8% | · | · | · | -773.3% | · | · | · | -1450.3% | · | · | |
| Pretax Margin | -1356.2% | -1489.2% | · | -1942.8% | -708.7% | -2753.1% | · | -1941.8% | -497.5% | -765.6% | · | -6371.0% | -2820.4% | -1472.9% | · | -3325.5% | |
| EBITDA Margin | -893.7% | -1283.5% | · | -1379.0% | -833.6% | -2510.0% | · | -1759.0% | -395.6% | -639.1% | · | -5819.3% | -2686.8% | -1392.9% | · | -4107.5% | |
| ROA | -10.3% | -7.7% | · | -10.5% | -5.7% | -6.3% | · | · | · | -9.4% | · | · | · | -11.1% | · | · | |
| ROE | -50.6% | -58.5% | · | -56.6% | -81.0% | -48.4% | · | · | · | -23.4% | · | · | · | -16.1% | · | · | |
| ROIC | -14.3% | -23.2% | · | -20.4% | -92.7% | -46.7% | · | -37.6% | -22.4% | -22.0% | · | -22.1% | -14.3% | -14.1% | · | -11.3% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.0 | 10.4 | · | 7.1 | 10.0 | 12.0 | · | 6.5 | 7.4 | 9.4 | · | 10.1 | 11.1 | 6.7 | · | 7.3 | |
| Quick Ratio | 5.0 | 2.4 | · | 5.9 | 6.2 | 6.0 | · | 3.5 | 3.6 | 3.8 | · | 3.3 | 7.5 | 2.3 | · | 6.9 | |
| Debt / Equity | 0.2 | 0.3 | · | 0.2 | -13.0 | 1.5 | · | 0.9 | 1.1 | 0.7 | · | 0.4 | 0.3 | 0.3 | · | 0.2 | |
| LT Debt / Equity | 0.2 | 0.3 | · | 0.2 | -13.0 | 1.5 | · | 0.9 | 1.1 | 0.7 | · | 0.4 | 0.3 | 0.3 | · | 0.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -3.4 | · | -5.3 | -9.5 | -20.8 | · | -19.4 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | 0.0 | · | · | · | · | · | · | |
| Receivables Turnover | 1.4 | 0.8 | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.67 | $2.37 | · | $3.68 | $-0.07 | $0.62 | · | $1.15 | $1.99 | $3.03 | · | $5.62 | $7.41 | $8.68 | · | $9.00 | |
| Revenue / Share | $0.09 | $0.06 | · | $0.06 | $0.10 | $0.03 | · | $0.05 | $0.23 | $0.18 | · | $0.03 | $0.05 | $0.11 | · | $0.03 | |
| Cash Flow / Share | · | $-0.61 | · | · | · | $-0.83 | · | · | · | $-1.25 | · | · | · | $-1.65 | · | · | |
| Cash / Share | $5.96 | $2.22 | · | $9.60 | $4.63 | $3.97 | · | $5.16 | $5.91 | $5.01 | · | $4.80 | $10.77 | $3.24 | · | $9.41 | |
| EPS (TTM) | $-4.02 | $-3.49 | · | $-4.38 | $-3.91 | $-4.38 | · | $-4.95 | $-5.92 | $-6.20 | · | $-4.80 | $-3.94 | $-3.34 | · | $-2.63 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $19M | $18M | · | $16M | $14M | $20M | · | $29M | $28M | $19M | · | $112M | $112M | $110M | · | $61M | |
| Net Income TTM | $-252M | $-209M | · | $-235M | $-199M | $-218M | · | $-240M | $-285M | $-297M | · | $-228M | $-187M | $-157M | · | $-125M | |
| Market Cap | $3.19B | $1.03B | · | $3.63B | $765M | $580M | · | $240M | $218M | $252M | · | $321M | $547M | $958M | · | $878M | |
| Enterprise Value | $2.83B | $941M | · | $3.08B | $563M | $414M | · | $40M | $33M | $111M | · | $193M | $134M | $907M | · | $540M | |
| P/E | -11.5 | -4.7 | · | -13.3 | -3.6 | -2.4 | · | -1.0 | -0.8 | -0.8 | · | -1.4 | -2.9 | -6.0 | · | -7.1 | |
| P/S | 171.0 | 57.0 | · | 230.4 | 53.3 | 28.7 | · | 8.4 | 7.9 | 13.3 | · | 2.9 | 4.9 | 8.7 | · | 14.3 | |
| P/B | 9.9 | 6.9 | · | 15.9 | -191.1 | 17.2 | · | 4.3 | 2.2 | 1.7 | · | 1.2 | 1.5 | 2.3 | · | 2.1 | |
| P / Tangible Book | 13.5 | 18.9 | · | 28.1 | · | · | · | · | 14.2 | 4.1 | · | 1.7 | 2.0 | 2.9 | · | 2.6 | |
| P / Cash Flow | · | -26.9 | · | · | · | -13.1 | · | · | · | -4.2 | · | · | · | -12.2 | · | · | |
| EV / Revenue | 151.6 | 52.0 | · | 195.8 | 39.3 | 20.5 | · | 1.4 | 1.2 | 5.9 | · | 1.7 | 1.2 | 8.2 | · | 8.8 | |
| Earnings Yield | -8.7% | -21.3% | · | -7.5% | -28.1% | -41.3% | · | -100.4% | -132.1% | -119.2% | · | -71.5% | -34.4% | -16.6% | · | -14.0% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $16M | $27M | $16M | $106M | $524M |
| Margine Operativo % | -1151.4% | -679.6% | -1785.5% | -134.4% | 59.3% |
| Utile netto | $-199M | $-240M | $-308M | $-127M | $330M |
| EPS Diluito | $-3.46 | $-4.92 | $-6.47 | $-2.71 | $7.04 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | 0.2 | -7.6 | 0.5 | 0.2 | 0.2 |
| Rapporto corrente | 10.4 | 9.7 | 8.8 | 6.3 | 17.1 |
| Quick Ratio | 1.3 | 4.0 | 3.3 | 3.0 | 15.1 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-178M | $-186M | $-153M | $-163M | $271M |
Proprietari istituzionali (13F) 312 filer · $3.6B totale · Aggiornato al 30 Settembre 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
312
Valore detenuto
$3.6B
Nuove posizioni
98
Posizioni chiuse
45
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 98 (+36 vs trimestre precedente) | 45 (-3 vs trimestre precedente) | 97 (+9 vs trimestre precedente) | 80 (+6 vs trimestre precedente) | +1.2M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| Avoro Capital Advisors LLC | $309.881.409 | 6.727.777 | 8,58% | Azioni |
| JPMORGAN CHASE & CO | $230.813.250 | 4.867.755 | 6,39% | Azioni |
| RTW INVESTMENTS, LP | $181.548.806 | 3.941.572 | 5,02% | Azioni |
| STATE STREET CORP | $133.750.180 | 2.903.825 | 3,70% | Azioni |
| Aberdeen Group plc | $131.184.269 | 2.848.117 | 3,63% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $118.728.862 | 2.577.700 | 3,29% | Opzione Call |
| BlackRock, Inc. | $86.475.484 | 1.877.453 | 2,39% | Azioni |
| ORBIMED ADVISORS LLC | $83.252.805 | 1.807.486 | 2,30% | Azioni |
| Caption Management, LLC | $74.967.256 | 1.627.600 | 2,07% | Opzione Call |
| JANE STREET GROUP, LLC | $74.178.847 | 1.610.483 | 2,05% | Azioni |
| JENNISON ASSOCIATES LLC | $71.918.636 | 1.561.412 | 1,99% | Azioni |
| Boxer Capital Management, LLC | $69.241.998 | 1.503.300 | 1,92% | Azioni |
| GOLDMAN SACHS GROUP INC | $67.982.533 | 1.475.956 | 1,88% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $67.340.825 | 1.462.024 | 1,86% | Azioni |
| Two Seas Capital LP | $66.391.345 | 1.441.410 | 1,84% | Azioni |
| FMR LLC | $58.499.338 | 1.270.068 | 1,62% | Azioni |
| MAK CAPITAL ONE LLC | $56.748.269 | 1.232.051 | 1,57% | Azioni |
| MPM BIOIMPACT LLC | $56.462.881 | 1.225.855 | 1,56% | Azioni |
| MORGAN STANLEY | $49.129.407 | 1.066.639 | 1,36% | Azioni |
| CITADEL ADVISORS LLC | $46.069.212 | 1.000.200 | 1,27% | Opzione Call |
| Vestal Point Capital, LP | $43.066.100 | 935.000 | 1,19% | Azioni |
| MAVERICK CAPITAL LTD | $42.623.141 | 925.383 | 1,18% | Azioni |
| CITADEL ADVISORS LLC | $41.930.168 | 910.338 | 1,16% | Azioni |
| Fiera Capital Corp | $41.875.034 | 909.141 | 1,16% | Azioni |
| Integral Health Asset Management, LLC | $41.454.000 | 900.000 | 1,15% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $39.658.136 | 860.631 | 1,10% | Azioni |
| Longaeva Partners L.P. | $37.059.600 | 804.594 | 1,03% | Azioni |
| Nantahala Capital Management, LLC | $36.848.000 | 800.000 | 1,02% | Opzione Call |
| VANGUARD CAPITAL MANAGEMENT LLC | $35.916.621 | 779.779 | 0,99% | Azioni |
| CITIGROUP INC | $30.629.900 | 665.000 | 0,85% | Opzione Call |
| Invesco Ltd. | $28.917.526 | 627.823 | 0,80% | Azioni |
| First Turn Management, LLC | $28.047.086 | 608.925 | 0,78% | Azioni |
| Point72 Asset Management, L.P. | $27.922.125 | 606.212 | 0,77% | Azioni |
| CITADEL ADVISORS LLC | $27.484.002 | 596.700 | 0,76% | Opzione Put |
| Balyasny Asset Management L.P. | $27.017.967 | 586.582 | 0,75% | Azioni |
| Kinetic Partners Management, LP | $26.760.860 | 581.000 | 0,74% | Azioni |
| BANK OF AMERICA CORP /DE/ | $26.658.884 | 578.786 | 0,74% | Azioni |
| TWO SIGMA ADVISERS, LP | $26.571.872 | 1.110.400 | 0,74% | Azioni |
| 683 Capital Management, LLC | $26.484.501 | 575.000 | 0,73% | Azioni |
| TUDOR INVESTMENT CORP ET AL | $25.254.698 | 548.300 | 0,70% | Opzione Call |
| JANE STREET GROUP, LLC | $25.231.668 | 547.800 | 0,70% | Opzione Call |
| VANGUARD GROUP INC | $25.159.500 | 1.051.379 | 0,70% | Azioni |
| GILDER GAGNON HOWE & CO LLC | $24.456.893 | 530.979 | 0,68% | Azioni |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | $24.028.443 | 521.677 | 0,66% | Azioni |
| Assenagon Asset Management S.A. | $23.653.192 | 513.530 | 0,65% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $22.887.076 | 496.897 | 0,63% | Azioni |
| UBS Group AG | $21.536.321 | 467.571 | 0,60% | Azioni |
| Nantahala Capital Management, LLC | $20.987.700 | 455.660 | 0,58% | Azioni |
| Voss Capital, LP | $20.743.628 | 450.361 | 0,57% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $19.349.806 | 420.100 | 0,54% | Opzione Put |
Attivisti e proprietari del 5%+ 1 partecipazione
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Coller Investment Management Limited, Coller International General Partner V, L.P, Coller International Partners V-A, L.P ×4 depositi | 03 Aprile 2019 | · | Deposito iniziale | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 28 insider · 17 dirigenti · 12 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Matthew C Kapusta | CEO, Managing Director | 02 Luglio 2026 M | 519.227 | 0 | 16 | $-12.864.927 |
| Christian Klemt | Chief Financial Officer | 04 Marzo 2026 A | 226.581 | 0 | 3 | $-381.751 |
| Ricardo Dolmetsch | President, R&D | 18 Settembre 2023 S | 163.404 | 0 | 0 | $0 |
| Pierre Caloz | Chief Operating Officer | 17 Giugno 2024 S | 115.707 | 0 | 0 | $0 |
| Scott T. Mcmillan | Chief Operating Officer | 28 Gennaio 2019 S | 20.432 | 0 | 0 | $0 |
| Walid Abi-Saab | Chief Medical Officer | 30 Giugno 2026 M | 148.235 | 0 | 7 | $-2.611.134 |
| Jeannette Potts | Chief Legal Officer | 15 Giugno 2026 S | 133.246 | 0 | 3 | $-261.172 |
| Kylie O'Keefe | Chief Customer & Strat Officer | 11 Giugno 2026 S | 108.864 | 0 | 1 | $-431.228 |
| Alexander Edward Kuta III | Executive VP, Operations | 07 Marzo 2023 S | 90.381 | 0 | 0 | $0 |
| Sander Van Deventer | EVP, Research & Product Dev. | 27 Febbraio 2020 A | 61.599 | 0 | 0 | $0 |
| Steven Zelenkofske | Chief Medical Officer | 06 Giugno 2018 S | 159.458 | 0 | 0 | $0 |
| Jonathan Garen | Chief Business Officer | 26 Gennaio 2018 A | 93.638 | 0 | 0 | $0 |
| Paul E Firuta | Chief Commercial Officer | 26 Gennaio 2018 A | 93.817 | 0 | 0 | $0 |
| Maria E Cantor | SVP, Investor Rel. & Comm. | 26 Gennaio 2018 A | 92.439 | 0 | 0 | $0 |
| Harald Petry | Chief Scientific Officer | 29 Giugno 2017 M | 0 | 0 | 0 | $0 |
| Christian Meyer | Chief Medical Officer | 27 Gennaio 2017 A | · | 0 | 0 | $0 |
| Maiken Keson-Brookes | General Counsel | 27 Gennaio 2017 A | · | 0 | 0 | $0 |
| Jack Kaye | Direttore | 30 Giugno 2026 M | 25.996 | 0 | 9 | $-2.693.581 |
| Madhavan Balachandran | Direttore | 17 Giugno 2026 M | 43.254 | 0 | 5 | $-858.916 |
| Rachelle Suzanne Jacques | Direttore | 10 Giugno 2026 A | 33.903 | 0 | 1 | $-53.931 |
| Jeremy P. Springhorn | Direttore | 10 Giugno 2026 A | 43.251 | 0 | 1 | $-53.931 |
| Robert Gut | Direttore | 10 Giugno 2026 A | 32.259 | 0 | 9 | $-1.757.850 |
| David D. Meek | Direttore | 10 Giugno 2026 A | 39.747 | 0 | 1 | $-53.931 |
| Leonard E Post | Direttore | 10 Giugno 2026 A | 35.494 | 0 | 1 | $-53.931 |
| Paula Soteropoulos | Direttore | 13 Giugno 2024 S | 20.203 | 0 | 0 | $0 |
| Philip Astley-Sparke | Direttore | 02 Marzo 2021 S | 9.946 | 0 | 0 | $0 |
| David Schaffer | Direttore | 27 Febbraio 2020 A | 46.978 | 0 | 0 | $0 |
| William Lewis | Direttore | 27 Gennaio 2017 A | · | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 12 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 1,06% | 131.294 SH | 02 Ottobre 2026 | Giornaliero |
| LABU · Direxion Shares ETF Trust | 0,72% | 81.217 NS | 31 Luglio 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,34% | 58.938 SH | 02 Ottobre 2026 | Giornaliero |
| IBB · iShares Trust | 0,21% | 492.076 SH | 11 Settembre 2026 | Giornaliero |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,11% | 4.906 SH | 02 Ottobre 2026 | Giornaliero |
| ESML · iShares Trust | 0,05% | 30.024 SH | 11 Settembre 2026 | Giornaliero |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 757.841 SH | 19 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,03% | 141.093 SH | 19 Agosto 2026 | Giornaliero |
| WSML · iShares Trust | 0,02% | 2.657 SH | 11 Settembre 2026 | Giornaliero |
| ITOT · iShares Trust | 0,00% | 89.136 SH | 11 Settembre 2026 | Giornaliero |
| ISCB · iShares Trust | · | 2.897 SH | 11 Settembre 2026 | Giornaliero |
| ISCV · iShares Trust | · | 14.325 SH | 11 Settembre 2026 | Giornaliero |
QURE Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 20 analisti
COMPRA
Target mediano
$69.54
+196,4%
7 35,0%
Acquisto forte
11 55,0%
Compra
2 10,0%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
11 analisti · 2026-10-03Target medio $65.48 +179,1%
← Sotto tutti i target
Prezzo attuale $23.46
Basso$30.80
Media$65.48
Alto$91.95
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
Ultime notizie Notizie recenti che menzionano questa società
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Lug 29, 2026